University of Idaho

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Idaho sits in the top decile of US sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count).

14 total trials 4 currently recruiting 10 completed early-phase tilt top decile by trial count

University of Idaho: 14 sponsored US clinical trials, 4 recruiting.

University of Idaho sponsors 14 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 10 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stress, with 2 trials.

Top-decile sponsor footprint

University of Idaho ranks in the top decile of sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

10 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

14 total, page 1 of 1

RECRUITING NA

Impact of Vitamin D Supplements on Mental Health and Milk Composition in Mothers Living in Idaho

NCT06919718
RECRUITING NA

Trout Consumption in Young Children and Families and Brain Health

NCT06721468
RECRUITING

Early Life Feeding Exposure and Infant Immune and Health Status.

NCT05986539
RECRUITING NA

Maternal Stress on Human Milk and Infant Outcomes

NCT04821544
COMPLETED NA

Can a Novel Manual Therapy Technique Help Relieve Stress? Assessing Effects of Primal Reflex Release on the Body's Stress Response

NCT06305585
COMPLETED NA

Feasibility of Egg-Based Diet Interventions and Assessing Perinatal Mental Health

NCT05619445
COMPLETED Phase 1

Creatine Supplementation and Resistance Training in Premenopausal Females

NCT05745870
COMPLETED NA

Creatine Supplementation in Female Collegiate Dancers

NCT05109039
COMPLETED NA

Determining the Impact of Emotive Intelligent Spaces

NCT04836286
COMPLETED NA

Investigating the Detection of Bovine and Soy Proteins in Human Milk

NCT04851340
COMPLETED NA

Poised for Parkinson's - an Intervention to Increase Embodied Agency in People With Parkinson's Disease and Their Carers

NCT04726709
COMPLETED NA

Dairy Based Probiotic Intervention and Cognitive, Emotional, and Inflammatory Outcomes

NCT04643080
COMPLETED NA

Onnit Labs New Mood Supplementation in Healthy College Students

NCT05109923
COMPLETED NA

Intervention for Pregnancy Related Pain

NCT03440073

Phase Distribution

PhaseTrial count
Phase 1 1

Therapeutic Areas

Stress 2
Well-Being, Psychological 1
Preterm Labor 1
Food Allergy in Infants 1
Maternal Stress 1
Breast Milk Collection 1
Maternal Obesity 1
Maternal Behavior 1
Postpartum Depression 1
Microbiome 1

What is open in the University of Idaho pipeline

4 recruiting of 14 indexed (29% open); 10 completed (71%).

Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).

Top condition: Stress (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Idaho: open-pipeline peers nationwide

Peers matched on 14 registered trials and 29% open enrollment, not the therapeutic-area sidebar.

University of Idaho sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0102030405060 0%10%20%30%40% Total trials Recruiting share University of Idaho3-C Institute for Social DevelopmentAbbott Medical OpticsAbbott RDx CardiometabolicAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA89bioAlabama Physical Therapy & AcupunctureAlloSourceAlnylam Pharmaceuticals
University of Idaho sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Idaho sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 14 trials (± recruiting share)

Sponsors near 29% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Idaho page

14 registered trials is a research-attention snapshot, not an endorsement of University of Idaho or any single study.

  • 4 of University of Idaho's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Stress is the condition University of Idaho studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stress trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Idaho pipeline card: 14 registered trials from official public datasets.Report a data error.